Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 146 | 2 | 146 | +2 |
| Shares | 43.1M | 154.8K | 44.0M | +1.03M (+2.4%) |
| Value | $206.7M | $741.3K | $202.1M | −$3.78M (−1.8%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 440,561 | $2.02M | 0.00% |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 190,536 | $874.6K | 0.00% |
| Caption Management, LLC | 78,383 | $359.8K | 0.02% |
| Walleye Capital LLC | 36,966 | $169.7K | 0.00% |
| Algert Global LLC | 26,910 | $123.5K | 0.00% |
| One68 Global Capital, LLC | 26,060 | $119.6K | 0.06% |
| Balyasny Asset Management LLC | 24,694 | $113.3K | 0.00% |
| Bailard, Inc. | 22,469 | $103.1K | 0.00% |
| Axq Capital, LP | 20,106 | $92.3K | 0.04% |
| Man Group plc | 17,361 | $79.7K | 0.00% |
| Envestnet Asset Management Inc | 16,364 | $75.1K | 0.00% |
| Virtu Financial LLC | 15,603 | $72.0K | 0.00% |
| Nations Financial Group Inc, | 14,500 | $66.6K | 0.01% |
| CIBC World Markets Corp | 12,649 | $58.1K | 0.00% |
| Linden Thomas Advisory Services, LLC | 10,649 | $48.9K | 0.01% |
| PVG Asset Management Corp | 10,375 | $47.6K | 0.21% |
| Coldstream Capital Management Inc | 2,650 | $12.2K | 0.00% |
| Persistent Asset Partners Ltd | 1,553 | $7.13K | 0.01% |
| Private Wealth Asset Management, LLC | 155 | $711 | 0.00% |
| Avion Wealth | 140 | $0 | 0.00% |
Sold out (18)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Commonwealth of Pennsylvania Public School Empls Retrmt Sys | 145,557 | $697.2K |
| Cubist Systematic Strategies, LLC | 108,835 | $521.3K |
| Jump Financial, LLC | 102,481 | $490.9K |
| Mackenzie Financial Corp | 50,012 | $239.6K |
| Diametric Capital, LP | 23,700 | $113.5K |
| Fox Run Management, L.L.C. | 19,247 | $92.2K |
| Simplex Trading, LLC | 16,659 | $79.0K |
| Savant Capital, LLC | 15,094 | $72.3K |
| Point72 (DIFC) Ltd | 11,176 | $53.5K |
| Wolverine Trading, LLC | 10,495 | $50.2K |
| Northwestern Mutual Wealth Management Co | 900 | $4.31K |
| Group One Trading, L.P. | 858 | $4.11K |
| Comerica Bank | 503 | $2.41K |
| Skopos Labs, Inc. | 437 | $2.09K |
| Harbour Investments, Inc. | 265 | $1.27K |
| R Squared Ltd | 140 | $671 |
| GAMMA Investing LLC | 32 | $153 |
| SRS Capital Advisors, Inc. | 9 | $44 |
Not filed for Q1 2025 yet (2)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 154,750 | $741.3K |
| Cassady Schiller Wealth Management, LLC | 10 | $48 |